ProTreatment Nørresundby ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 2.1% 2.0% 2.2% 3.6%  
Credit score (0-100)  0 68 68 65 52  
Credit rating  N/A A A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.1 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,297 1,509 1,198 1,067  
EBITDA  0.0 923 1,142 911 768  
EBIT  0.0 104 315 77.5 -67.7  
Pre-tax profit (PTP)  0.0 -132.8 116.5 -161.1 -435.2  
Net earnings  0.0 -103.8 90.9 -125.6 -339.7  
Pre-tax profit without non-rec. items  0.0 -133 117 -161 -435  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 154 153 138 82.5  
Shareholders equity total  0.0 -63.8 27.1 -98.6 -438  
Interest-bearing liabilities  0.0 6,321 8,004 6,156 5,626  
Balance sheet total (assets)  0.0 7,924 8,438 6,424 5,520  

Net Debt  0.0 6,073 8,004 6,155 5,626  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,297 1,509 1,198 1,067  
Gross profit growth  0.0% 0.0% 16.4% -20.6% -11.0%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 7,924 8,438 6,424 5,520  
Balance sheet change%  0.0% 0.0% 6.5% -23.9% -14.1%  
Added value  0.0 923.3 1,142.4 905.0 767.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 6,357 -1,609 -1,629 -1,671  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 8.1% 20.9% 6.5% -6.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 1.3% 3.8% 1.0% -1.1%  
ROI %  0.0% 1.4% 4.0% 1.1% -1.1%  
ROE %  0.0% -1.3% 2.3% -3.9% -5.7%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% -0.8% 0.3% -1.5% -7.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 657.8% 700.6% 676.0% 732.8%  
Gearing %  0.0% -9,906.5% 29,589.6% -6,243.5% -1,283.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 7.5% 2.8% 3.4% 6.2%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.5 0.7 0.5 0.4  
Current Ratio  0.0 0.5 0.7 0.5 0.4  
Cash and cash equivalent  0.0 247.7 0.3 0.4 -0.3  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -828.0 -711.6 -750.3 -1,042.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 923 1,142 905 768  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 923 1,142 911 768  
EBIT / employee  0 104 315 78 -68  
Net earnings / employee  0 -104 91 -126 -340